The Association between Influenza Treatment and Hospitalization-Associated Outcomes among Korean Children with Laboratory-Confirmed Influenza.
10.3346/jkms.2014.29.4.485
- Author:
Jacqueline K LIM
1
;
Tae Hee KIM
;
Paul E KILGORE
;
Allison E AIELLO
;
Byung Min CHOI
;
Kwang Chul LEE
;
Kee Hwan YOO
;
Young Hwan SONG
;
Yun Kyung KIM
Author Information
1. International Vaccine Institute, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Influenza, Human;
Hospitalizations;
Oseltamivir;
Therapeutics;
Child
- MeSH:
Adolescent;
Anti-Bacterial Agents/*therapeutic use;
Antigens, Viral/analysis/immunology;
Antiviral Agents/*therapeutic use;
Child;
Child, Preschool;
Cohort Studies;
Demography;
Drug Therapy, Combination;
Female;
Hospitalization;
Humans;
Infant;
Infant, Newborn;
Influenza A virus/metabolism;
Influenza B virus/metabolism;
Influenza, Human/*drug therapy;
Male;
Oseltamivir/*therapeutic use;
Republic of Korea;
Retrospective Studies
- From:Journal of Korean Medical Science
2014;29(4):485-493
- CountryRepublic of Korea
- Language:English
-
Abstract:
There are limited data evaluating the relationship between influenza treatment and hospitalization duration. Our purpose assessed the association between different treatments and hospital stay among Korean pediatric influenza patients. Total 770 children < or = 15 yr-of-age hospitalized with community-acquired laboratory-confirmed influenza at three large urban tertiary care hospitals were identified through a retrospective medical chart review. Demographic, clinical, and cost data were extracted and a multivariable linear regression model was used to assess the associations between influenza treatment types and hospital stay. Overall, there were 81% of the patients hospitalized with laboratory-confirmed influenza who received antibiotic monotherapy whereas only 4% of the patients received oseltamivir monotherapy. The mean treatment-related charges for hospitalizations treated with antibiotics, alone or with oseltamivir, were significantly higher than those treated with oseltamivir-only (P < 0.001). Influenza patients treated with antibiotics-only and antibiotics/oseltamivir combination therapy showed 44.9% and 28.2%, respectively, longer duration of hospitalization compared to those treated with oseltamivir-only. Patients treated with antibiotics, alone or combined with oseltamivir, were associated with longer hospitalization and significantly higher medical charges, compared to patients treated with oseltamivir alone. In Korea, there is a need for more judicious use of antibiotics, appropriate use of influenza rapid testing.
